Log in to save to my catalogue

Liver‐directed gene therapy for ornithine aminotransferase deficiency

Liver‐directed gene therapy for ornithine aminotransferase deficiency

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e07eec5ef9114bf685675cb9215d0081

Liver‐directed gene therapy for ornithine aminotransferase deficiency

About this item

Full title

Liver‐directed gene therapy for ornithine aminotransferase deficiency

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2023-04, Vol.15 (4), p.e17033-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Gyrate atrophy of choroid and retina (GACR) is a chorioretinal degeneration caused by pathogenic variants in the gene encoding ornithine aminotransferase (OAT), an enzyme mainly expressed in liver. Affected patients have increased ornithine concentrations in blood and other body fluids and develop progressive constriction of vision fields leading t...

Alternative Titles

Full title

Liver‐directed gene therapy for ornithine aminotransferase deficiency

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e07eec5ef9114bf685675cb9215d0081

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e07eec5ef9114bf685675cb9215d0081

Other Identifiers

ISSN

1757-4676,1757-4684

E-ISSN

1757-4684

DOI

10.15252/emmm.202217033

How to access this item